Zhou BP, Hung MC. Dysregulation of cellular signaling by HER2/neu in breast cancer. Semin Oncol. 2003;30:38–48.
Article
CAS
Google Scholar
Loibl S, Gianni L. HER2-positive breast cancer. Lancet. 2017;389:2415–29.
Article
CAS
Google Scholar
Waks AG, Winer EP. Breast cancer treatment: a review. JAMA. 2019;321:288–300.
Article
CAS
Google Scholar
Gianni L, Eiermann W, Semiglazov V, Manikhas A, Lluch A, Tjulandin S, Zambetti M, Vazquez F, Byakhow M, Lichinitser M, et al. Neoadjuvant chemotherapy with trastuzumab followed by adjuvant trastuzumab versus neoadjuvant chemotherapy alone, in patients with HER2-positive locally advanced breast cancer (the NOAH trial): a randomised controlled superiority trial with a parallel HER2-negative cohort. Lancet. 2010;375:377–84.
Article
CAS
Google Scholar
Llombart-Cussac A, Cortes J, Pare L, Galvan P, Bermejo B, Martinez N, Vidal M, Pernas S, Lopez R, Munoz M, et al. HER2-enriched subtype as a predictor of pathological complete response following trastuzumab and lapatinib without chemotherapy in early-stage HER2-positive breast cancer (PAMELA): an open-label, single-group, multicentre, phase 2 trial. Lancet Oncol. 2017;18:545–54.
Article
CAS
Google Scholar
Prat A, Cheang MC, Galvan P, Nuciforo P, Pare L, Adamo B, Munoz M, Viladot M, Press MF, Gagnon R, et al. Prognostic value of intrinsic subtypes in hormone receptor-positive metastatic breast cancer treated with letrozole with or without lapatinib. JAMA Oncol. 2016;2:1287–94.
Article
Google Scholar
Harbeck N. Neoadjuvant and adjuvant treatment of patients with HER2-positive early breast cancer. Breast. 2022;62(Suppl 1):S12–6.
Article
Google Scholar
Geisel J, Raghu M, Hooley R. The role of ultrasound in breast cancer screening: the case for and against ultrasound. Semin Ultrasound CT MR. 2018;39:25–34.
Article
Google Scholar
Hooley RJ, Scoutt LM, Philpotts LE. Breast ultrasonography: state of the art. Radiology. 2013;268:642–59.
Article
Google Scholar
Elias SG, Adams A, Wisner DJ, Esserman LJ, et al. Imaging features of HER2 overexpression in breast cancer: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2014;23:1464–83.
Article
CAS
Google Scholar
Gumowska M, Maczewska J, Prostko P, Roszkowska-Purska K, Dobruch-Sobczak K. Is there a correlation between multiparametric assessment in ultrasound and intrinsic subtype of breast cancer? J Clin Med. 2021. https://doi.org/10.3390/jcm10225394.
Article
Google Scholar
Wu L, Zhao Y, Lin P, Qin H, Liu Y, Wan D, Li X, He Y, Yang H. Preoperative ultrasound radiomics analysis for expression of multiple molecular biomarkers in mass type of breast ductal carcinoma in situ. BMC Med Imaging. 2021;21:84.
Article
CAS
Google Scholar
Guo Y, Hu Y, Qiao M, Wang Y, Yu J, Li J, Chang C. Radiomics analysis on ultrasound for prediction of biologic behavior in breast invasive ductal carcinoma. Clin Breast Cancer. 2018;18:e335–44.
Article
Google Scholar
Ma M, Liu R, Wen C, Xu W, Xu Z, Wang S, Wu J, Pan D, Zheng B, Qin G, Chen W. Predicting the molecular subtype of breast cancer and identifying interpretable imaging features using machine learning algorithms. Eur Radiol. 2022;32:1652–62.
Article
CAS
Google Scholar
Lambin P, Leijenaar RTH, Deist TM, Peerlings J, de Jong EEC, van Timmeren J, Sanduleanu S, Larue R, Even AJG, Jochems A, et al. Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol. 2017;14:749–62.
Article
Google Scholar
Youk JH, Kwak JY, Lee E, Son EJ, Kim JA. Grayscale ultrasound radiomic features and shear-wave elastography radiomic features in benign and malignant breast masses. Ultraschall Med. 2020;41:390–6.
Article
Google Scholar
Luo WQ, Huang QX, Huang XW, Hu HT, Zeng FQ, Wang W. Predicting breast cancer in breast imaging reporting and data system (BI-RADS) ultrasound category 4 or 5 lesions: a nomogram combining radiomics and BI-RADS. Sci Rep. 2019;9:11921.
Article
Google Scholar
Lee SE, Han K, Kwak JY, Lee E, Kim EK. Radiomics of US texture features in differential diagnosis between triple-negative breast cancer and fibroadenoma. Sci Rep. 2018;8:13546.
Article
Google Scholar
Romeo V, Cuocolo R, Apolito R, Stanzione A, Ventimiglia A, Vitale A, Verde F, Accurso A, Amitrano M, Insabato L, et al. Clinical value of radiomics and machine learning in breast ultrasound: a multicenter study for differential diagnosis of benign and malignant lesions. Eur Radiol. 2021;31:9511–9.
Article
Google Scholar
Pinker K, Chin J, Melsaether AN, Morris EA, Moy L. Precision medicine and radiogenomics in breast cancer: new approaches toward diagnosis and treatment. Radiology. 2018;287:732–47.
Article
Google Scholar
Iwatate Y, Hoshino I, Yokota H, Ishige F, Itami M, Mori Y, Chiba S, Arimitsu H, Yanagibashi H, Nagase H, Takayama W. Radiogenomics for predicting p53 status, PD-L1 expression, and prognosis with machine learning in pancreatic cancer. Br J Cancer. 2020;123:1253–61.
Article
CAS
Google Scholar
Toro-Dominguez D, Martorell-Marugan J, Lopez-Dominguez R, Garcia-Moreno A, Gonzalez-Rumayor V, Alarcon-Riquelme ME, Carmona-Saez P. ImaGEO: integrative gene expression meta-analysis from GEO database. Bioinformatics. 2019;35:880–2.
Article
CAS
Google Scholar
Wang C, Liu H, Yang M, Bai Y, Ren H, Zou Y, Yao Z, Zhang B, Li Y. RNA-seq based transcriptome analysis of endothelial differentiation of bone marrow mesenchymal stem cells. Eur J Vasc Endovasc Surg. 2020;59:834–42.
Article
Google Scholar
Yeh AC, Li H, Zhu Y, Zhang J, Khramtsova G, Drukker K, Edwards A, McGregor S, Yoshimatsu T, Zheng Y, et al. Radiogenomics of breast cancer using dynamic contrast enhanced MRI and gene expression profiling. Cancer Imaging. 2019;19:48.
Article
Google Scholar
Villarino AV, Kanno Y, O’Shea JJ. Mechanisms and consequences of Jak-STAT signaling in the immune system. Nat Immunol. 2017;18:374–84.
Article
CAS
Google Scholar
Fan M, Xia P, Clarke R, Wang Y, Li L. Radiogenomic signatures reveal multiscale intratumour heterogeneity associated with biological functions and survival in breast cancer. Nat Commun. 2020;11:4861.
Article
CAS
Google Scholar
Bismeijer T, van der Velden BHM, Canisius S, Lips EH, Loo CE, Viergever MA, Wesseling J, Gilhuijs KGA, Wessels LFA. Radiogenomic analysis of breast cancer by linking MRI phenotypes with tumor gene expression. Radiology. 2020;296:277–87.
Article
Google Scholar
Sun Q, Chen Y, Liang C, Zhao Y, Lv X, Zou Y, Yan K, Zheng H, Liang D, Li ZC. Biologic pathways underlying prognostic radiomics phenotypes from paired MRI and RNA sequencing in glioblastoma. Radiology. 2021;301:654–63.
Article
Google Scholar
Saha A, Harowicz MR, Grimm LJ, Kim CE, Ghate SV, Walsh R, Mazurowski MA. A machine learning approach to radiogenomics of breast cancer: a study of 922 subjects and 529 DCE-MRI features. Br J Cancer. 2018;119:508–16.
Article
CAS
Google Scholar
Wolff AC, Hammond MEH, Allison KH, Harvey BE, Mangu PB, Bartlett JMS, Bilous M, Ellis IO, Fitzgibbons P, Hanna W, et al. Human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists Clinical practice guideline focused update. J Clin Oncol. 2018;36:2105–22.
Article
CAS
Google Scholar
van Griethuysen JJM, Fedorov A, Parmar C, Hosny A, Aucoin N, Narayan V, Beets-Tan RGH, Fillion-Robin JC, Pieper S, Aerts H. Computational radiomics system to decode the radiographic phenotype. Cancer Res. 2017;77:e104–7.
Article
Google Scholar
Yu G, Wang LG, Han Y, He QY. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16:284–7.
Article
CAS
Google Scholar
Choong GM, Cullen GD, O’Sullivan CC. Evolving standards of care and new challenges in the management of HER2-positive breast cancer. CA Cancer J Clin. 2020;70:355–74.
Article
Google Scholar
Wang Y, Ikeda DM, Narasimhan B, Longacre TA, Bleicher RJ, Pal S, Jackman RJ, Jeffrey SS. Estrogen receptor-negative invasive breast cancer: imaging features of tumors with and without human epidermal growth factor receptor type 2 overexpression. Radiology. 2008;246:367–75.
Article
Google Scholar
Ko ES, Lee BH, Kim HA, Noh WC, Kim MS, Lee SA. Triple-negative breast cancer: correlation between imaging and pathological findings. Eur Radiol. 2010;20:1111–7.
Article
Google Scholar
O’Grady S, Morgan MP. Microcalcifications in breast cancer: from pathophysiology to diagnosis and prognosis. Biochim Biophys Acta Rev Cancer. 2018;1869:310–20.
Article
CAS
Google Scholar
Mazari FAK, Sharma N, Dodwell D, Horgan K. Human epidermal growth factor 2-positive breast cancer with mammographic microcalcification: relationship to pathologic complete response after neoadjuvant chemotherapy. Radiology. 2018;288:366–74.
Article
Google Scholar
Scimeca M, Giannini E, Antonacci C, Pistolese CA, Spagnoli LG, Bonanno E. Microcalcifications in breast cancer: an active phenomenon mediated by epithelial cells with mesenchymal characteristics. BMC Cancer. 2014;14:286.
Article
Google Scholar
Wang Z, Liang W, Ma C, Wang J, Gao X, Wei L. Macrophages inhibit ciliary protein levels by secreting bmp-2 leading to airway epithelial remodeling under cigarette smoke exposure. Front Mol Biosci. 2021;8: 663987.
Article
CAS
Google Scholar
Hu CT, Shao YD, Liu YZ, Xiao X, Cheng ZB, Qu SL, Huang L, Zhang C. Oxidative stress in vascular calcification. Clin Chim Acta. 2021;519:101–10.
Article
CAS
Google Scholar